Evidence map›Paper›PMID 42701408›Full record

ReviewJournal of pharmaceutical analysis2026

Advancements in pharmaceutical research on traditional Chinese medicine-metal complexes.

Minyu Han, Jinning Mao, Guodong Liu, Peng Xue

Abstract readReview
In one paragraph

Review in Journal of pharmaceutical analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Minyu HanSchool of Materials and Energy, Southwest University, Chongqing, 400715, China.
Jinning MaoHealth Medical Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Guodong LiuDepartment of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Peng XueSchool of Materials and Energy, Southwest University, Chongqing, 400715, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese medicine (TCM) has gained significant recognition as an adjuvant treatment modality for cancer, infections, and inflammatory diseases, owing to its outstanding antitumor, antimicrobial, and anti-inflammatory properties. With the advancement of TCM-based coordination chemistry, TCM-metal complexes have attracted growing interest in recent years. These novel compounds, formed by integrating traditional TCM components with metal ions, not only enhance the therapeutic efficacy of TCM but also exhibit unique biological activities. This review highlights the design strategies and pharmaceutical applications of various categories of TCM-metal complexes, including those based on polyphenols, alkaloids, and other drug-metal conjugates. By applying modern nanobiotechnology alongside TCM principles, TCM-metal complexes demonstrate considerable potential for the diagnosis and treatment of major diseases. Finally, this review discusses the challenges and future prospects of TCM-metal complexes in clinical applications, providing valuable insights to guide further research and development in this emerging field.

Indexed as

Coordination chemistryNanobiotechnologyPharmaceutical applicationsTraditional Chinese medicine

Identifiers

PMID42701408
PMCPMC13545372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.